.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Argus Health
Fish and Richardson
Mallinckrodt
Daiichi Sankyo
UBS
Chinese Patent Office
Johnson and Johnson
Dow
Colorcon

Generated: November 21, 2017

DrugPatentWatch Database Preview

Drug Master Files for: furosemide

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
1834III11/22/1971HOECHST CELANESE CORPFUROSEMIDE
2565AII11/12/1975TEVA PHARMACEUTICAL INDUSTRIES LTDFUROSEMIDE USP
2649III4/2/1976SOLMAG SPAFUROSEMIDE
3033III9/15/1977PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKSFUROSEMIDE USP
3134III1/24/1978CIECH POLFAFUROSEMIDE
3265III4/11/1978SCHARPER SPAFUROSEMIDE
3331III10/20/1978CHINOIN PHARMACEUTCIAL AND CHEMICAL WORKS CO LTDFUROSEMIDE USP XIX, BULK
3364III8/29/1978DINAMITE DIPHARMA SPAFUROSEMIDE USP
3435III1/25/1979ORION CORP FARMOS CHEMICAL PLANTFUROSEMIDE
3513AII3/8/1979FIS FABBRICA ITALIANA SINTETICI SPAFUROSEMIDE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Cerilliant
Harvard Business School
Covington
Citi
McKinsey
Boehringer Ingelheim
Fish and Richardson
US Department of Justice
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot